These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 8553066)
1. Toward an understanding of the correlates of protective immunity to HIV infection. Haynes BF; Pantaleo G; Fauci AS Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066 [TBL] [Abstract][Full Text] [Related]
2. Immunology and the elusive AIDS vaccine. Virgin HW; Walker BD Nature; 2010 Mar; 464(7286):224-31. PubMed ID: 20220841 [TBL] [Abstract][Full Text] [Related]
3. Immune reconstitution inflammatory syndrome of the small bowel in a human immunodeficiency virus-negative patient. Daum S; Loddenkemper C; Schneider T Clin Gastroenterol Hepatol; 2007 Jul; 5(7):e27-8. PubMed ID: 17628330 [No Abstract] [Full Text] [Related]
4. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development. Betts MR; Gray CM; Cox JH; Ferrari G Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631 [TBL] [Abstract][Full Text] [Related]
5. Dancing with an escape artist. Deweerdt S Nature; 2010 Jul; 466(7304):S6-7. PubMed ID: 20631705 [No Abstract] [Full Text] [Related]
6. Animal models for the study of human immunodeficiency virus infections. Letvin NL Curr Opin Immunol; 1992 Aug; 4(4):481-5. PubMed ID: 1356349 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977 [TBL] [Abstract][Full Text] [Related]
8. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. Card CM; McLaren PJ; Wachihi C; Kimani J; Plummer FA; Fowke KR J Infect Dis; 2009 May; 199(9):1318-22. PubMed ID: 19301980 [TBL] [Abstract][Full Text] [Related]
9. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates. GarcĂa-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M J Virol; 2017 May; 91(9):. PubMed ID: 28179536 [TBL] [Abstract][Full Text] [Related]
10. CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children. Levy JA; Hsueh F; Blackbourn DJ; Wara D; Weintrub PS J Infect Dis; 1998 Feb; 177(2):470-2. PubMed ID: 9466540 [TBL] [Abstract][Full Text] [Related]
11. The immunopathogenesis of HIV infection. Rosenberg ZF; Fauci AS Adv Immunol; 1989; 47():377-431. PubMed ID: 2573256 [No Abstract] [Full Text] [Related]
12. Short Communication: Immune Activation Is Present in HIV-1-Exposed Seronegative Individuals and Is Independent of Microbial Translocation. Saulle I; Biasin M; Gnudi F; Rainone V; Ibba SV; Lo Caputo S; Mazzotta F; Trabattoni D; Clerici M AIDS Res Hum Retroviruses; 2016 Feb; 32(2):129-33. PubMed ID: 26414485 [TBL] [Abstract][Full Text] [Related]
13. Protective immunity against HIV infection: lessons from HIV-2 infection. Rowland-Jones S Future Microbiol; 2006 Dec; 1(4):427-33. PubMed ID: 17661633 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons. Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351 [TBL] [Abstract][Full Text] [Related]
15. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. Casimiro DR; Chen L; Fu TM; Evans RK; Caulfield MJ; Davies ME; Tang A; Chen M; Huang L; Harris V; Freed DC; Wilson KA; Dubey S; Zhu DM; Nawrocki D; Mach H; Troutman R; Isopi L; Williams D; Hurni W; Xu Z; Smith JG; Wang S; Liu X; Guan L; Long R; Trigona W; Heidecker GJ; Perry HC; Persaud N; Toner TJ; Su Q; Liang X; Youil R; Chastain M; Bett AJ; Volkin DB; Emini EA; Shiver JW J Virol; 2003 Jun; 77(11):6305-13. PubMed ID: 12743287 [TBL] [Abstract][Full Text] [Related]
16. [HIV infection and long-term non progressor]. Suzuki Y; Yamamoto N Nihon Rinsho; 1997 Jun; 55(6):1563-71. PubMed ID: 9200949 [TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen. McElrath MJ; Corey L; Greenberg PD; Matthews TJ; Montefiori DC; Rowen L; Hood L; Mullins JI Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3972-7. PubMed ID: 8633000 [TBL] [Abstract][Full Text] [Related]
18. Correlates of protection in HIV infection and the progression of HIV infection to AIDS. Clerici M; Shearer GM Immunol Lett; 1996 Jun; 51(1-2):69-73. PubMed ID: 8811347 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 and AIDS: what are protective immune responses? Beattie T; Rowland-Jones S; Kaul R J HIV Ther; 2002 May; 7(2):35-9. PubMed ID: 12553686 [TBL] [Abstract][Full Text] [Related]
20. A strategy for prophylactic vaccination against HIV. Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553 [No Abstract] [Full Text] [Related] [Next] [New Search]